Clinical Trial Update: Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy [Phase 4]

View source ↗

Summary

A completed Phase 4 safety trial evaluating the nasal spray Atrovent (ipratropium bromide) in pediatric patients with rhinorrhea associated with a common cold o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Common Cold

Drugs mentioned

• Atrovent (ipratropium bromide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Cold | Phase 4 | Status: COMPLETED